FINASTERIDE TABLETS
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Finasteride Tablets. This will be an unrestricted and fully competitive acquisition for a firm-fixed price, requirements type contract.
Scope of Work
This opportunity seeks a national supply source for:
- Finasteride Tablets 5MG in 30, 90, and 500 count bottles. The resulting contract will provide these items for purchase by the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through DLA and VA prime vendor programs.
Contract & Timeline
- Type: Firm-Fixed Price, Requirements Contract (FAR 52.216-21)
- Duration: One-year base period with four one-year options
- Set-Aside: None (Unrestricted and fully competitive)
- Solicitation Method: Commercial item acquisition using FAR Part 12
- Projected Solicitation Date: December 2023 (Note: This is a pre-solicitation; the actual solicitation date may vary).
- Published: February 1, 2024
Evaluation
All sources may submit a proposal, which will be considered by the agency.
Additional Notes
The solicitation will be posted on the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov. Interested parties are advised to set up automated notifications for updates. For questions, contact Phyllis Daraio at phyllis.daraio@dla.mil or 215-737-7941.